Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Research Solutions, Inc is an information technology services business based in the US. Research Solutions shares (RSSS) are listed on the NASDAQ and all prices are listed in US Dollars. Research Solutions employs 139 staff and has a trailing 12-month revenue of around USD$31.2 million.
|Latest market close||USD$2.28|
|52-week range||USD$2.05 - USD$3.7|
|50-day moving average||USD$2.2968|
|200-day moving average||USD$2.5075|
|Wall St. target price||USD$1.81|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.04|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-08)||-5.79%|
|1 month (2020-12-16)||1.79%|
|3 months (2020-10-15)||-4.20%|
|6 months (2020-07-15)||-5.39%|
|1 year (2020-01-15)||-32.54%|
|2 years (2019-01-15)||1.33%|
|3 years (2018-01-12)||N/A|
|5 years (2016-01-12)||N/A|
|Revenue TTM||USD$31.2 million|
|Gross profit TTM||USD$9.6 million|
|Return on assets TTM||-3.34%|
|Return on equity TTM||-16.4%|
|Market capitalisation||USD$61.4 million|
TTM: trailing 12 months
There are currently 12,101 Research Solutions shares held short by investors – that's known as Research Solutions's "short interest". This figure is 62.7% down from 32,449 last month.
There are a few different ways that this level of interest in shorting Research Solutions shares can be evaluated.
Research Solutions's "short interest ratio" (SIR) is the quantity of Research Solutions shares currently shorted divided by the average quantity of Research Solutions shares traded daily (recently around 34574.285714286). Research Solutions's SIR currently stands at 0.35. In other words for every 100,000 Research Solutions shares traded daily on the market, roughly 350 shares are currently held short.
However Research Solutions's short interest can also be evaluated against the total number of Research Solutions shares, or, against the total number of tradable Research Solutions shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Research Solutions's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Research Solutions shares in existence, roughly 0 shares are currently held short) or 0.001% of the tradable shares (for every 100,000 tradable Research Solutions shares, roughly 1 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Research Solutions.
Find out more about how you can short Research Solutions stock.
We're not expecting Research Solutions to pay a dividend over the next 12 months.
Over the last 12 months, Research Solutions's shares have ranged in value from as little as $2.05 up to $3.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Research Solutions's is 0.8371. This would suggest that Research Solutions's shares are less volatile than average (for this exchange).
Research Solutions, Inc., through its subsidiaries, provides annual licenses that allow customers to access and utilize features of cloud based software-as-a-service research intelligence platform. The company is also involved in the transactional sale of published scientific, technical, and medical content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to speed up research and development activities with single sourced access and management of content and data used in the intellectual property development lifecycle. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was founded in 2006 and is based in Henderson, Nevada.
Everything we know about the Vacasa IPO, plus information on how to buy in.
Everything we know about the William Penn Bancorp IPO, plus information on how to buy in.
Everything we know about the Landos Biopharma Inc IPO, plus information on how to buy in.
Everything we know about the First High-School Education Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Knowlton Development Corp IPO, plus information on how to buy in.
Steps to owning and managing SASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAIL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAF, with 24-hour and historical pricing before you buy.
Steps to owning and managing RDHL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBFG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.